Product guide · Restricted substance
Smart Brothers Dr Semax 60 caps
Peptide product from Smart Brothers, 60 capsules. This guide sets out what the manufacturer states about the composition of Smart Brothers Dr Semax 60 caps, what independent research says about its main ingredient, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.
Back to the product- Named ingredients
- 1
- Amounts stated
- All
- Status
- Restricted substance
- Evidence summaries
- 1
Overview
Manufacturer informationSmart Brothers Dr Semax 60 caps contains N-Acetyl semax: 300 mcg per capsule. Each pack holds 60 capsules.
Ingredients & composition
Manufacturer information| Ingredient | Amount |
|---|---|
| N-Acetyl semax | 300 mcg per capsule |
Scientific background
Independent researchSemax
Semax is a synthetic peptide analogue of a fragment of the hormone ACTH (ACTH 4–10). It has been used clinically in Russia, mainly in stroke care1.
Research evidence
Independent researchSemax
Published clinical studies, mostly from Russia and in Russian, report effects in people with ischaemic stroke1. There are no controlled trials in healthy people supporting cognitive enhancement.
Evidence limitations
Independent researchNo published study has tested this specific product; the research summarised here concerns the ingredient itself.
Semax
The trials are few, from a limited number of centres, and not in healthy users1.
Safety & potential risks
Independent researchSemax
Safety outside medical supervision is not established. Reviewers describe a "gray market" of unapproved peptides sold directly to consumers outside regulatory oversight, with uncertain purity and safety2.
Regulatory status
Contains a peptide that is not authorised as food (including food supplements) or as a medicinal product in the EU. No dosing information for human use is provided.
Scientific references
- Gusev EI, Martynov MY, Kostenko EV, et al. The efficacy of semax in the treatment of patients at different stages of ischemic stroke [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118:61-68. PubMed 29798983
- Mendias CL, Awan TM. Safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries and athletic performance. Sports Med. 2026;56:1921-1935. PubMed 41966639
- Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
- Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
- World Anti-Doping Agency. The Prohibited List (current edition). Source
Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.
The product
Smart Brothers Dr Semax 60 caps
€69,90 · Sold out